Jefferies Financial Group Inc. Exelixis, Inc. Call Options Transaction History

Jefferies Financial Group Inc.

  • $8.87 Billion
  • Q2 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$19.25 - $24.13 $1.39 Million - $1.74 Million
72,000 New
72,000 $1.73 Million
Q2 2023

Aug 14, 2023
BUY
$18.17 - $20.48 $261,648 - $294,912
14,400 Added 17.65%
96,000 $1.83 Million
Q1 2023

May 15, 2023
BUY
$16.3 - $19.41 $1.33 Million - $1.58 Million
81,600 New
81,600 $1.58 Million

Others Institutions Holding EXEL

# of Institutions
460
Shares Held
240M
Call Options Held
2.04M
Put Options Held
1.29M
View Full List

About EXELIXIS, INC.

EXEL Quotes by TradingView
  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $8.35B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email